Differential Network Analysis Reveals Genetic Effects on Catalepsy Modules

We performed short-term bi-directional selective breeding for haloperidol-induced catalepsy, starting from three mouse populations of increasingly complex genetic structure: an F2 intercross, a heterogeneous stock (HS) formed by crossing four inbred strains (HS4) and a heterogeneous stock (HS-CC) formed from the inbred strain founders of the Collaborative Cross (CC). All three selections were successful, with large differences in haloperidol response emerging within three generations. Using a custom differential network analysis procedure, we found that gene coexpression patterns changed significantly; importantly, a number of these changes were concordant across genetic backgrounds. In contrast, absolute gene-expression changes were modest and not concordant across genetic backgrounds, in spite of the large and similar phenotypic differences. By inferring strain contributions from the parental lines, we are able to identify significant differences in allelic content between the selected lines concurrent with large changes in transcript connectivity. Importantly, this observation implies that genetic polymorphisms can affect transcript and module connectivity without large changes in absolute expression levels. We conclude that, in this case, selective breeding acts at the subnetwork level, with the same modules but not the same transcripts affected across the three selections.

[1]  Leonid Kruglyak,et al.  Catecholamine receptor polymorphisms affect decision-making in C. elegans , 2011, Nature.

[2]  R. Burke,et al.  Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease , 2009, Nature Neuroscience.

[3]  A. C. Collins,et al.  A method for fine mapping quantitative trait loci in outbred animal stocks. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Horvath,et al.  Conservation and evolution of gene coexpression networks in human and chimpanzee brains , 2006, Proceedings of the National Academy of Sciences.

[5]  J. Ahn,et al.  Combinatorial, selective and reversible control of gene expression using oligodeoxynucleotides in a cell‐free protein synthesis system , 2009, Biotechnology and bioengineering.

[6]  Bin Zhang,et al.  Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R , 2008, Bioinform..

[7]  S. Horvath,et al.  Variations in DNA elucidate molecular networks that cause disease , 2008, Nature.

[8]  M. Webster,et al.  Association between SNPs and gene expression in multiple regions of the human brain , 2012, Translational Psychiatry.

[9]  J. Smiley,et al.  Mesencephalic dopamine neuron number and tyrosine hydroxylase content: Genetic control and candidate genes , 2007, Neuroscience.

[10]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[11]  S. Bronson,et al.  Loss of G Protein γ7 Alters Behavior and Reduces Striatal αolf Level and cAMP Production* , 2003, The Journal of Biological Chemistry.

[12]  W. Valdar,et al.  Detecting Major Genetic Loci Controlling Phenotypic Variability in Experimental Crosses , 2011, Genetics.

[13]  Robert W. Williams,et al.  Genetic regulation of Nrnx1 expression: an integrative cross-species analysis of schizophrenia candidate genes , 2011, Translational Psychiatry.

[14]  C. Farber,et al.  Identification of a gene module associated with BMD through the integration of network analysis and genome‐wide association data , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[16]  S. Horvath,et al.  Functional organization of the transcriptome in human brain , 2008, Nature Neuroscience.

[17]  J. Deussing,et al.  Genetic mouse models for behavioral analysis through transgenic RNAi technology , 2008, Genes, brain, and behavior.

[18]  M. Muers,et al.  Technology: Getting Moore from DNA sequencing , 2011, Nature Reviews Genetics.

[19]  R. Hitzemann,et al.  D1 and D2 dopamine receptor distribution in the neuroleptic nonresponsive and neuroleptic responsive lines of mice, a quantitative receptor autoradiographic study. , 1992, The Journal of pharmacology and experimental therapeutics.

[20]  M. Chesselet,et al.  Genetic mouse models of Parkinson's disease The state of the art. , 2010, Progress in brain research.

[21]  R. Hitzemann,et al.  Detection and Mapping of Quantitative Trait Loci for Haloperidol-Induced Catalepsy in a C57BL/6J×DBA/2J F2 Intercross , 1999, Behavior genetics.

[22]  Y. Xing,et al.  A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.

[23]  Wei Wang,et al.  The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics , 2007, Mammalian Genome.

[24]  C. A. French,et al.  An aetiological Foxp2 mutation causes aberrant striatal activity and alters plasticity during skill learning , 2011, Molecular Psychiatry.

[25]  Riccardo Zecchina,et al.  Inference of sparse combinatorial-control networks from gene-expression data: a message passing approach , 2010, BMC Bioinformatics.

[26]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[27]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[28]  Daniel E. Zak,et al.  PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. , 2003, Omics : a journal of integrative biology.

[29]  B. Malmanger,et al.  Further studies on using multiple-cross mapping (MCM) to map quantitative trait loci , 2006, Mammalian Genome.

[30]  A. Ansari,et al.  Expanding the specificity of DNA targeting by harnessing cooperative assembly. , 2008, Biochimie.

[31]  L. Excoffier,et al.  Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. , 1992, Genetics.

[32]  Megan K. Mulligan,et al.  Toward understanding the genetics of alcohol drinking through transcriptome meta-analysis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Min Chen,et al.  Comparing Statistical Methods for Constructing Large Scale Gene Networks , 2012, PloS one.

[34]  Shannon McWeeney,et al.  Genetic diversity and striatal gene networks: focus on the heterogeneous stock-collaborative cross (HS-CC) mouse , 2010, BMC Genomics.

[35]  M. Muers Systems biology: Plant networks , 2011, Nature Reviews Genetics.

[36]  Lisa E. Gralinski,et al.  The Genome Architecture of the Collaborative Cross Mouse Genetic Reference Population , 2012, Genetics.

[37]  R. Hitzemann,et al.  D1 and D2 dopamine receptor turnover and D2 messenger RNA levels in the neuroleptic-responsive and the neuroleptic nonresponsive lines of mice. , 1993, The Journal of pharmacology and experimental therapeutics.

[38]  S. McWeeney,et al.  Gene networks and haloperidol‐induced catalepsy , 2012, Genes, brain, and behavior.

[39]  E. Thomas,et al.  Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease , 2008, Neurobiology of Disease.

[40]  J. Belknap,et al.  Short-Term Selective Breeding as a Tool for QTL Mapping: Ethanol Preference Drinking in Mice , 1997, Behavior genetics.

[41]  M. S. Mukhtar,et al.  Independently Evolved Virulence Effectors Converge onto Hubs in a Plant Immune System Network , 2011, Science.

[42]  A. Nishi,et al.  Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: biochemical and behavioral profiles of phosphodiesterase inhibition in dopaminergic neurotransmission. , 2010, Journal of pharmacological sciences.

[43]  Albert-László Barabási,et al.  Scale-free networks , 2008, Scholarpedia.

[44]  R. Hitzemann,et al.  Animal Models of Psychiatric Disorders and Their Relevance to Alcoholism , 2000, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[45]  Rui Luo,et al.  Is My Network Module Preserved and Reproducible? , 2011, PLoS Comput. Biol..

[46]  S. Kanes,et al.  Mapping the genes for haloperidol-induced catalepsy. , 1996, The Journal of pharmacology and experimental therapeutics.

[47]  G. Fisone,et al.  Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice , 2009, Trends in Neurosciences.

[48]  Sandhya Mehrotra,et al.  Combinatorial Control of Gene Expression , 2013, BioMed research international.

[49]  Daniel Bottomly,et al.  Utilizing RNA-Seq data for de novo coexpression network inference , 2012, Bioinform..

[50]  P. Baldi,et al.  Genome-Wide Identification of Bcl11b Gene Targets Reveals Role in Brain-Derived Neurotrophic Factor Signaling , 2011, PloS one.

[51]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[52]  R. Hitzemann,et al.  Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome 14. , 1999, The Journal of pharmacology and experimental therapeutics.

[53]  S. Kanes,et al.  On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice. , 1993, The Journal of pharmacology and experimental therapeutics.

[54]  N. Walter,et al.  Characterization of the quantitative trait locus for haloperidol‐induced catalepsy on distal mouse chromosome 1 , 2008, Genes, brain, and behavior.

[55]  Thomas M. Keane,et al.  Mouse genomic variation and its effect on phenotypes and gene regulation , 2011, Nature.

[56]  R. Hitzemann,et al.  Genetics and the organization of the basal ganglia. , 1995, International review of neurobiology.

[57]  S. Hébert,et al.  LRRK2 in Transcription and Translation Regulation: Relevance for Parkinson’s Disease , 2012, Front. Neur..